A mathematical approach to virus therapy of glioblastomas

Victor Lopez de Rioja1, Neus Isern2, Joaquim Fort3

  • 1ICREA/Complex Systems Laboratory, Departament de Física, Universitat de Girona, Girona, 17071, Catalonia, Spain.

Biology Direct
|January 8, 2016
PubMed
Abstract

Insights

Mathematical models incorporating time-delay effects accurately predict oncolytic Vesicular Stomatitis Virus (VSV) lytic action on glioblastoma (GBM) in vitro. This research enhances viral therapy models for cancer treatment.

Area of Science:

  • Oncology
  • Virology
  • Mathematical Biology

Background:

  • Glioblastoma (GBM) treatment may benefit from oncolytic virus therapy.
  • Vesicular Stomatitis Virus (VSV) exhibits potent oncolytic properties.
  • Previous mathematical models for virus-tumor interactions lacked quantitative comparison with experimental data.

Purpose of the Study:

  • To quantitatively compare mathematical models with in vitro experimental data for VSV treatment of GBM.
  • To develop and refine mathematical models that incorporate time-delay effects for virus-tumor dynamics.
  • To predict the lytic action speed of VSV on glioblastoma.

Main Methods:

  • Development of three mathematical models of increasing complexity, incorporating time-delay effects.
  • Application of models to in vitro experimental data of VSV and GBM.
  • Analysis of virus dynamics and tumor front speed using the developed models.

Main Results:

  • A comprehensive model with time-delay effects in reactive and diffusive terms accurately matched experimental virus speed data.
  • The tumor speed was predicted by a simple function yielding results within the experimental range.
  • Model validation against in vitro experimental data for VSV-GBM interaction.

Conclusions:

  • The refined mathematical model, incorporating time-delay effects, accurately predicts VSV's lytic action speed on GBM in vitro.
  • Time delay (τ) is identified as a critical parameter in these models.
  • The study provides a foundation for simulating in vivo oncolytic virus therapy for various cancers.

Related Concept Videos